Podcast & Infographic

Artificial Intelligence (AI) in Paediatric Endocrinology: How does it Compare with Clinical Skills?

Paul Dimitri, UK

LAUNCH 13 JUNE 2025

Click to Listen to the Podcast

Download the infographic

Overview

History, physical examination and auxology remain the most important methods for understanding the reasons for short stature [Collett-Solberg, 2019]. Recognition of some syndromes develops with experience and exposure to patients and is helped by examination of the child and careful direct questioning of both child and/or their parent/guardian. Milder cases of both growth hormone deficiency and growth hormone insensitivity are less well-defined and can overlap with those labelled as having idiopathic short stature (ISS) [Savage, 2021]. There is great promise that digital health technologies can improve outcomes in paediatric growth disorders by supporting personalisation of care, from diagnosis to treatment and follow up [Dunkel, 2021]. The use of artificial intelligence (AI) to remove problems with variability that can occur during growth information analysis [Dunkel, 2021] is an exciting area of development, with facial recognition software being used to identify subtle facial changes and dysmorphic features that may be present in certain conditions. For example, facial recognition machine learning models have been used to identify patients with Turner syndrome with a diagnostic accuracy of 97% and subtypes of Noonan syndrome [Dimitri, 2024; Pan, 2021; Huang, 2024; Yang 2021].

Learning Objectives

At the end of the podcast, learners should be able to:

Target Audience

Paediatricians working in growth disorder management, general practitioners and specialist growth disorder nurses.

Language

Language: English with voice over into Spanish and Korean

Artificial Intelligence (AI) in Paediatric Endocrinology: How does it Compare with Clinical Skills?

Launch 13 June 2025

Faculty

Paul Dimitri

Paul Dimitri

Consultant in Paediatric Endocrinology
Professor of Child Health Technology, University of Sheffield
Professor of Child Health, Sheffield Hallam University
Director of Innovation and Child Health Technology, Sheffield Children’s Hospital
Vice President for Science & Research, The Royal College of Paediatrics & Child Health
Clinical Director, NIHR HealthTech Research Centre in Paediatrics and Child Health
Clinical Director, Technology Innovation Transforming Child Health
Sheffield, UK

Save The Date

Download

· Martin O. Savage ·

Martin Savage is Emeritus Professor of Paediatric Endocrinology at William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary, University of London. He was head of the Paediatric Endocrine Unit at Barts and the London School of Medicine from 1982 to 2007. He has interests in growth disorders, specifically those with abnormalities in the GH-IGF-1 axis and in phenotype-genotype relationships of GH-IGF-1 axis defects, notably GH resistance. He published the first human case of an IGF-1 gene defect in the New England Journal of Medicine in 1996.  His other interests are Cushing’s syndrome and growth in chronic inflammatory diseases. He was General Secretary of the European Society for Paediatric Endocrinology (ESPE) from 1997 to 2004. He has lectured in 60 countries and has published 482 original articles, reviews, textbook chapters and books. In 2007, he was awarded the ESPE Andrea Prader Prize for contributions to paediatric endocrinology and in 2018 he received a Visionary Award from the American Human Growth Foundation. In 2022, he received a Research Excellence Award from the Dr Sulaiman Al Habib Medical Journal in Riyadh, and the British Society of Paediatric Endocrinology & Diabetes James M. Tanner Lifetime Achievement Award. He continues to lecture nationally and internationally.

· Paul Dimitri ·

Paul Dimitri BSc, MBChB, FRCPCH, PhD is a Consultant in Paediatric Endocrinology at Sheffield Children’s NHS Foundation Trust, Professor of Child Health Technology at the University of Sheffield, and Professor of Child Health at Sheffield Hallam University. He has worked in paediatrics since 1998 and paediatric endocrinology since 2004, with clinical expertise in disorders of growth, puberty, and hormone regulation. He leads the Hypothalamic and Pituitary Tumour Service and co‑leads the Paediatric Late Effects Endocrinology service supporting childhood cancer survivors with endocrine complications. His research spans child health technology, endocrinology, and skeletal development, and he is widely published in these fields. Professor Dimitri is Director of the NIHR HealthTech Research Centre in Paediatrics and Child Health and Clinical Director of the national TITCH Network, driving innovation in child health technology. He previously directed the NIHR CYP MedTech Cooperative, the UK’s first paediatric MedTech Co‑operative, and served as NIHR National Children’s Specialty Lead from 2016–2024. He is Vice President for Science and Research at the Royal College of Paediatrics and Child Health, shaping national research policy. In 2025, he was awarded NIHR Senior Investigator status, recognising his leadership in applied child health research and his commitment to transforming healthcare for children and young people.

Join our Newsletter!

Stay in the know with our CME updates

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.